Enjoy complimentary customisation on priority with our Enterprise License!
The assisted reproductive technology market size is forecast to increase by USD 8.23 billion between 2022 and 2027, accelerating at a CAGR of 5.79%. The market's growth hinges on various factors, including the increase in the rate of infertility and obesity-related cases. Additionally, there's a rise in awareness of ART (Assisted Reproductive Technology) and an increase in the income level of consumers. These factors collectively contribute to the expanding scope of fertility treatments and services, driving the demand for ART solutions. As awareness grows and income levels rise, more individuals and couples seek access to advanced reproductive technologies to overcome challenges and fulfill their desire for parenthood.
To learn more about this report, Download Report Sample
The research report of the Assisted Reproductive Technology Market offers industry forecasts and segmentation based on Application including fertility clinics, hospitals, and others. It also segments the market by Type, which comprises IVF and Artificial Insemination. Geographically, the report covers Europe, North America, Asia, and Rest of World (RoW).
The market is influenced by various factors. Rising junk food intake, smoking, and alcoholism contribute to fertility issues, driving demand for fertility treatments. Social shifts like late marriages and stressful lifestyles affect fertility rates, increasing the need for reproductive assistance. Surrogacy, fertility drugs, and advanced medical procedures offer solutions but raise ethical concerns. Trends include a growing acceptance of same-sex marriages and technological advancements in reproductive endocrinology. Challenges include the high costs of fertility treatments, ethical dilemmas, and the risk of prematurity. Adherence to ethical standards and ongoing research are essential for addressing these challenges.
The increase in the rate of infertility and obesity-related cases is a key factor driving the market growth. The market is propelled by two key factors: the increasing prevalence of infertility and obesity-related issues. Infertility is a widespread concern, impacting many couples due to factors like advanced maternal age, hormonal disorders, genetics, lifestyle choices, and infections. As infertility rates rise, there's a growing demand for ART procedures like in vitro fertilization (IVF) and intrauterine insemination (IUI). This surge in demand fuels the ART market as more individuals and couples turn to these techniques to overcome and achieve successful pregnancies.
Obesity has also become a global epidemic, adversely affecting fertility for both men and women. Conditions like polycystic ovary syndrome (PCOS) and insulin resistance, linked to obesity, disrupt normal reproductive function and increase infertility risk. Moreover, obesity can affect the success rates of ART procedures. The mounting cases of obesity-related infertility drive the demand for ART treatments to aid those facing fertility challenges, contributing to the growth of the ART market. These combined factors are expected to influence the ART market positively during the forecast period.
The market is influenced by various factors such as junk food intake, smoking, alcoholism, and drug addiction, which can impact fertility. Societal trends like late marriages and stressful lifestyles also contribute to the demand for ART. Ethical considerations surrounding surrogacy, embryo use, and fertility treatment costs are crucial in this field. With advancements in reproductive endocrinology and the availability of fertility drugs, the market continues to evolve. Additionally, legal and ethical issues surrounding same-sex marriages and reproductive rights are important factors shaping the landscape of ART. The market encompasses a range of procedures, including fresh and frozen non-donor IVF, catering to diverse patient needs and preferences.
Further, in the realm of ART, addressing socio-ethical issues and understanding medical procedure costs is paramount. Factors like crude birth rate and female fertility significantly impact the demand for ART services. The market also considers biological components such as embryos and gametes, along with the anatomical aspects like the uterus, vagina, and placenta. Organizations like the World Health Organization play a pivotal role in setting standards and guidelines for ART practices. Fresh non-donor procedures further diversify the options available to patients seeking assistance with such challenges.
Fertility Clinics Segment is the Leading Segment to Dominate the Market
The fertility clinics segment showed a gradual increase in the market share of USD 13.41 billion in 2017 and continue to grow by 2021. Fertility clinics dominated the global ART market owing to a worldwide increase in the number of centers to meet the unmet and increasing number of patients that have subsequently increased consumption of ART solutions. A key factor the increase would influence the inflow of infertility patients is the high increase in the success rate of infertility clinics globally.
Market - Revenue Share by Application Segment, 2017-2027
For more details on other segments, Download Sample Report
Europe Holds a Prominent Position in the Market
Europe is estimated to contribute 32% to the growth of the global market during the forecast period. The growth of the European market is driven by the increasing elderly population facing infertility issues due to declining egg quality, impacting couples' ability to conceive. In 2022, major contributions to the European market came from Italy, the UK, Germany, France, and Spain. With fertility rates averaging around 1.5 children per woman in most European countries, there's a growing trend of women seeking advanced treatments, creating opportunities for hospitals and clinics in the forecast period.
Government and non-government organizations have ramped up awareness campaigns to educate the public about fertility complications and treatment options. End-users in the region encounter challenges such as high treatment costs and stringent regulations governing services at hospitals and clinics. Belgium, Israel, and the Czech Republic have become tourism hubs, offering favorable reimbursement policies and advanced ART techniques. Additionally, countries like Israel, Belgium, France, Slovenia, and the Netherlands provide full insurance coverage for ART, with varying coverage for treatment cycles. Israel's government has also subsidized ART costs.
Market Size, By Region, Global 2017-2027
To understand geographic trends Download Report Sample
The Assisted Reproductive Technology Market is fragmented in nature. Some significant players include Cook Group Inc., CRITEX GmbH, Cryolab Ltd., Esco Micro Pte. Ltd., Ferring BV, FUJIFILM Holdings Corp.
The market growth and forecasting research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Hamilton Thorne Ltd., IMV Technologies, Instituto Bernabeu SL, INVO Bioscience Inc., KITAZATO Corp., Merck KGaA, Monash IVF Group Ltd., Pantec Engineering AG, Smiths Group Plc, The Cooper Companies Inc., Virtus Health, Vitrolife AB, XiltriX International, and Genea Ltd.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2023-2027, as well as historical data from 2017-2021 for the following segments.
In the landscape of ART, various elements shape the market dynamics. The advocacy efforts of organizations like the Human Rights Campaign underscore the importance of reproductive rights. Cryopreservation techniques enable the preservation of fertility potential, expanding options for individuals facing fertility challenges. The pharmaceutical market plays a crucial role in providing fertility medications to aid in reproductive treatments. Both fresh donor and frozen donor options, along with embryo or egg banking, offer diverse pathways to parenthood. Procedures like ovulation induction and various insemination methods cater to minor fertility conditions. ART serves diverse demographics, including same-sex couples and single women, providing inclusive solutions. However, challenges such as reduced success rate underscore the ongoing need for innovation and advancement in the field of reproductive medicine.
Further, various techniques and interventions aim to address such challenges. Fertility medication plays a pivotal role in stimulating ovulation and optimizing reproductive health. Procedures such as intracervical insemination, intravaginal insemination, and intratubal insemination offer targeted approaches to facilitate conception. Additionally, Frozen Embryo Replacement (FER) enables the transfer of cryopreserved embryos, enhancing reproductive options. Biological factors like the Angiotensin-converting enzyme 2 and the health of the ovaries influence outcomes. Despite advancements, challenges persist, including reduced success rates, necessitating ongoing research and innovation in the field of reproductive medicine.
Market Scope |
|
Report Coverage |
Details |
Page number |
159 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.79% |
Market growth 2023-2027 |
USD 8.23 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
4.37 |
Regional analysis |
Europe, North America, Asia, and Rest of World (ROW) |
Performing market contribution |
Europe at 32% |
Key countries |
US, UK, Germany, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Cook Group Inc., CRITEX GmbH, Cryolab Ltd., Esco Micro Pte. Ltd., Ferring BV, FUJIFILM Holdings Corp., Hamilton Thorne Ltd., IMV Technologies, Instituto Bernabeu SL, INVO Bioscience Inc., KITAZATO Corp., Merck KGaA, Monash IVF Group Ltd., Pantec Engineering AG, Smiths Group Plc, The Cooper Companies Inc., Virtus Health, Vitrolife AB, XiltriX International, and Genea Ltd. |
Market dynamics |
Parent market growth analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.